GMGinny Moore

Ginny Moore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ginny Moore has a total of 361 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Waterborne Outbreak of Mycobacterium abscessus in a UK Specialist Heart and Lung Hospital 2019–2026: Patients, Mitigations, and Implications

    by Ellen Heinsbroek, Uta Hill, Olly Allen, Kathy Randall, Caroline Patterson, Iain Roddick, Richard Puleston, Mark Reacher, Neville Q Verlander, Lynsey Emmett, et al.

    Background: Three months after a major cardiothoracic hospital in England relocated to a new building, 2 cases of Mycobacterium abscessus occurred among lung transplant recipients, triggering an outbreak investigation. Methods: Respiratory samples were collected from transplant recipients and patients with cystic fibrosis (CF) and non-CF bronchiectasis and tested for M. abscessus (other patient groups on clinical request). Environmental sampling was undertaken between 2019 and 2025. Whole genome sequencing (WGS) was performed on clinical and environmental specimens. An outbreak case was defined as a patient with a positive culture matching the strain from water samples on WGS. Epidemiological investigations included assessment of clinical outcomes, calculation of incidence rates, and a case-control study among transplant recipients. Results: Between May 2019 and June 2026, 40 outbreak cases occurred in lung transplant recipients (n = 11), patients with CF (n = 11) or non-CF bronchiectasis (n = 14), and other patient groups (n = 4), of whom 19 were diagnosed with nontuberculous mycobacterial pulmonary disease. The case-control study found no specific risk factors associated with lung transplant surgery or bronchoscopy. Environmental sampling showed that the outbreak strain had persisted and disseminated throughout the hospital water system. Following extensive control measures, including point-of-use filters and biocide treatment, incidence fell from 12.8 to 2.2 cases per year. No further case has been identified since June 2025, coinciding with a review of enhanced flushing. Conclusions: Control measures reduced the incidence of infection but did not eliminate the outbreak strain from the hospital water. Risk mitigation is needed for water systems where vulnerable patients are accommodated.


  • Open Access

    The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England

    by Christopher R. Jones, Claire Neill, Andrew M. Borman, Emma L. Budd, Martina Cummins, Carole Fry, Rebecca L. Guy, Katie Jeffery, Elizabeth M. Johnson, Rohini Manuel, et al.

    The emergent fungal pathogen Candida auris is increasingly recognised as an important cause of healthcare-associated infections globally. It is highly transmissible, adaptable, and persistent, resulting in an organism with significant outbreak potential that risks devastating consequences. Progress in the ability to identify C. auris in clinical specimens is encouraging, but laboratory diagnostic capacity and surveillance systems are lacking in many countries. Intrinsic resistance to commonly used antifungals, combined with the ability to rapidly acquire resistance to therapy, substantially restricts treatment options and novel agents are desperately needed. Despite this, outbreaks can be interrupted, and mortality avoided or minimised, through the application of rigorous infection prevention and control measures with an increasing evidence base. This review provides an update on epidemiology, the impact of the COVID-19 pandemic, risk factors, identification and typing, resistance profiles, treatment, detection of colonisation, and infection prevention and control measures for C. auris. This review has informed a planned 2024 update to the United Kingdom Health Security Agency (UKHSA) guidance on the laboratory investigation, management, and infection prevention and control of Candida auris. A multidisciplinary response is needed to control C. auris transmission in a healthcare setting and should emphasise outbreak preparedness and response, rapid contact tracing and isolation or cohorting of patients and staff, strict hand hygiene and other infection prevention and control measures, dedicated or single-use equipment, appropriate disinfection, and effective communication concerning patient transfers and discharge.


  • Open Access

    A 17-month longitudinal surface sampling study carried out on public transport vehicles operating in England during the COVID-19 pandemic identified low levels of SARS-CoV-2 RNA contamination

    by Paz Aranega-Bou, Thomas Pottage, Abigail Fenwick, Wilhemina D'COsta, Natalie F Brown, Nicola Yaxley, Marco-Felipe King, Simon T Parker, Daniel Miller, Martín López-García, et al.

    To monitor severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA contamination in vehicles operating in England during the pandemic, to better understand transmission risk of SARS-CoV-2 on public transport. We collected 1314 surface samples between December 2020 and April 2022 on trains and buses managed by five different transport operators. The presence of SARS-CoV-2 RNA was investigated through reverse transcription polymerase chain reaction (RT-PCR). SARS-CoV-2 RNA was found on 197 (15%) of the 1314 surfaces sampled, including seat head rests, handholds, and air extract grilles, but the levels of RNA recovered on those samples (median value of 23.4, interquartile range: 14.3–35.4, N gene copies per extraction) made the presence of infectious virus at the time of sampling extremely unlikely. However, detection rates varied over time with peaks broadly coinciding with times of high community transmission, when it was more likely that people infected with SARS-CoV-2 were travelling on public transport. During the pandemic, and as in other public spaces, low levels of SARS-CoV-2 RNA were found on surfaces associated with public transport.


  • Open Access

    A 17-month longitudinal environmental sampling study carried out on public transport vehicles operating in England during the COVID-19 pandemic identified low levels of SARS-CoV-2 RNA contamination

    by Paz Aranega-Bou, Thomas Pottage, Abigail Fenwick, Wilhemina D’costa, Natalie F. Brown, Nicola Yaxley, Marco-Felipe King, Simon T. Parker, Daniel Miller, Martín López-García, et al.

    Aims: To monitor severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA contamination in vehicles operating in England during the pandemic, to better understand transmission risk of SARS-CoV-2 on public transport. Methods and Results: We collected 1,314 surface samples between December 2020 and April 2022 on trains and buses managed by five different transport operators. The presence of SARS-CoV-2 RNA was investigated through reverse transcription polymerase chain reaction (RT-PCR). SARS-CoV-2 RNA was found on 197 (15%) of the 1,314 surfaces sampled, including seat head rests, handholds, and air extract grilles, but the levels of RNA recovered on those samples (median value of 23.4, inter-quartile range: 14.3-35.4, N gene copies per extraction) made the presence of infectious virus at the time of sampling extremely unlikely. However, detection rates varied over time with peaks broadly coinciding with times of high community transmission, suggesting that people infected with SARS-CoV-2 when travelling on public transport could create opportunities for transmission. Conclusion: During the pandemic, and as in other public spaces, low levels of SARS-CoV-2 RNA were found on surfaces associated with public transport. Impact statement: The results of this study will inform modelling approaches and the implementation of mitigation strategies to minimise the risk of transmission of respiratory viruses in public transport.

  • Open Access

    A workflow for the detection of antibiotic residues, measurement of water chemistry and preservation of hospital sink drain samples for metagenomic sequencing

    by Gillian Rodger, Kevin Chau, Paz Aranega-Bou, Aysha Roohi, Ginny Moore, Katie L Hopkins, Susan Hopkins, A Sarah Walker, Nicole Stoesser

    Structured summary: Background: Hospital sinks are environmental reservoirs that harbour healthcare-associated (HCA) pathogens. Selective pressures in sink environments, such as antibiotic residues, nutrient waste and hardness ions, may promote antibiotic resistance gene (ARG) exchange between bacteria. However, cheap and accurate sampling methods to characterise these factors are lacking. Aim: To validate a workflow to detect antibiotic residues and evaluate water chemistry using dipsticks. Secondarily, to validate boric acid to preserve the taxonomic and ARG (“resistome”) composition of sink trap samples for metagenomic sequencing. Methods: Antibiotic residue dipsticks were validated against serial dilutions of ampicillin, doxycycline, sulfamethoxazole and ciprofloxacin, and water chemistry dipsticks against serial dilutions of chemical calibration standards. Sink trap aspirates were used for a “real-world” pilot evaluation of dipsticks. To assess boric acid as a preservative of microbial diversity, the impact of incubation with and without boric acid at ∼22°C on metagenomic sequencing outputs was evaluated at Day 2 and Day 5 compared with baseline (Day 0). Findings: The limits of detection for each antibiotic were: 3µg/L (ampicillin), 10µg/L (doxycycline), 20µg/L (sulfamethoxazole) and 8µg/L (ciprofloxacin). The best performing water chemistry dipstick correctly characterised 34/40 (85%) standards in a concentration-dependent manner. One trap sample tested positive for the presence of tetracyclines and sulfonamides. Taxonomic and resistome composition were largely maintained after storage with boric acid at ∼22°C for up to five days. Conclusions: Dipsticks can be used to detect antibiotic residues and characterise water chemistry in sink trap samples. Boric acid was an effective preservative of trap sample composition, representing a low-cost alternative to cold-chain transport.

  • Open Access

    Detection, survival, and persistence of Staphylococcus capitis NRCS-A in neonatal units in England

    by G. Moore, A. Barry, J. Carter, J. Ready, Y. Wan, M. Elsayed, C. Haill, M. Khashu, O.M. Williams, C.S. Brown, et al.


  • Open Access

    Whole-genome sequencing reveals widespread presence of Staphylococcus capitis NRCS-A clone in neonatal units across the United Kingdom

    by Yu Wan, Mark Ganner, Zaynab Mumin, Derren Ready, Ginny Moore, Isabelle Potterill, Karthik Paranthaman, Elita Jauneikaite, Bharat Patel, Alessandra Harley, et al.


  • Open Access

    Environmental sampling for SARS-CoV-2 in long term care facilities: lessons from a pilot study

    by Rachel Kwiatkowska, Nicola Yaxley, Ginny Moore, Allan Bennett, Matthew Donati, Nicola Love, Roberto Vivancos, Matthew Hickman, Derren R Ready

    Background: The SARS-CoV-2 pandemic has highlighted the risk of infection in long-term care facilities (LTCF) and the vulnerability of residents to severe outcomes. Environmental surveillance may help detect pathogens early and inform Infection Prevention and Control (IPC) measures in these settings. Methods: Upon notification of SARS-CoV-2 outbreaks, LTCF within a local authority in South West England were approached to take part in this pilot study. Investigators visited to swab common touch-points and elevated ‘non-touch’ surfaces (>1.5m above ground level) and samples were analysed for presence of SARS-CoV-2 genetic material (RNA). Data were collected regarding LTCF infrastructure, staff behaviours, clinical and epidemiological risk factors for infection (staff and residents), and IPC measures. Criteria for success were: recruitment of three LTCF; detection of SARS-COV-2 RNA; variation in proportion of SARS-CoV-2 positive surfaces by sampling zone; and collection of clinical and epidemiological data for context. Results: Three LTCFs were recruited, ranging in size and resident demographics. Outbreaks lasted 63, 50 and 30 days with resident attack rates of 53%, 40% and 8%, respectively. The proportion of sample sites on which SARS-CoV-2 was detected was highest in rooms occupied by infected residents and varied elsewhere in the LTCF, with low levels in a facility implementing enhanced IPC measures. The heterogeneity of settings and difficulty obtaining data made it unfeasible to assess association between environmental contamination and infection. A greater proportion of elevated surfaces tested positive for SARS-CoV-2 RNA than common touch-points. Conclusions: SARS-CoV-2 RNA can be detected in a variety of LTCF outbreak settings, both on common-touch items and in elevated sites out of reach. This suggests that further work is justified, to assess feasibility and utility of environmental sampling for infection surveillance in LTCF.

  • Open Access

    WITHDRAWN: Evaluation of Fourier Transform Infrared spectroscopy (IR Biotyper) as a complement to Whole genome sequencing (WGS) to characterise Enterobacter cloacae , Citrobacter freundii and Klebsiella pneumoniae isolates recovered from hospital sinks

    by P Aranega-Bou, C Cornbill, G Rodger, M Bird, G Moore, A Roohi, Kl Hopkins, S Hopkins, P Ribeca, N Stoesser, et al.

    Whole genome sequencing (WGS) of healthcare-associated pathogens is recognised as the gold standard for isolate typing and the recognition of transmission networks and outbreaks. However, it remains reasonably expensive to process small numbers of isolates in real-time, and frequently requires specific expertise to enable both sequencing and the analysis of sequencing outputs, limiting its generalisability and turnaround. Spectrometry has revolutionised species identification in clinical laboratory workflows, and has more recently been applied to strain-level identification to facilitate low-cost, routine strain typing in clinical laboratories. However, studies to date of its clinical performance for strain-level typing are conflicting, and limited evaluation has been undertaken on environmental healthcare-associated isolates. We therefore compared its performance with WGS for Enterobacter cloacae, Citrobacter freundii and Klebsiella pneumoniae isolated from sink drains across nine hospitals and investigated whether it could be used as a screening tool prior to WGS. We found its sensitivity and specificity to cluster isolates when compared with WGS were generally poor and highly variable dependent on species and the single nucleotide polymorphism (SNP) distance threshold used to cluster isolates. Impact statement Enterobacterales are key pathogens of concern in healthcare-associated infections and have been shown to be disseminated via environmental reservoirs in hospitals. Accurately evaluating strain-based transmission networks amongst patients and hospital environments is critical to optimising infection prevention and control interventions. The current gold standard approach to characterise these transmission networks is to use genome sequencing of isolates, but this remains expensive and challenging to do routinely in many clinical laboratories. Bacterial characterisation based on protein spectra has been widely implemented for species identification in diagnostic microbiology, and devices such as Bruker’s matrix-assisted laser desorption/ionization time-of-flight (MALDI-ToF) mass spectrometry system (MALDI Biotyper) have revolutionised workflows, reducing both costs and turnaround. Bruker have introduced another device, known as the IR Biotyper, which aims to use infrared spectroscopy to characterise strain-level variability and facilitate outbreak investigation. Our study shows that when compared to whole genome sequencing, the IR Biotyper cannot be used reliably to type collections of isolates collected from the hospital sink environment, which might limit its suitability to investigate outbreaks associated with this environmental reservoir. Data summary The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files. Raw isolate sequencing data are deposited in NCBI (BioProject accession: PRJNA925315). Supplementary data files, phylogenetic and IR Biotyper trees are deposited in Figshare https://doi.org/10.6084/m9.figshare.22016009.v1


  • Open Access

    Environmental screening for SARS-CoV-2 in long term care facilities: lessons from a pilot study

    by Rachel Kwiatkowska, Nicola Yaxley, Ginny Moore, Allan Bennett, Matthew Donati, Nicola Love, Roberto Vivancos, Matthew Hickman, Derren R Ready

    Background: The SARS-CoV-2 pandemic has highlighted the risk of infection transmission in long-term care facilities (LTCF) and the vulnerability of resident populations. It is essential to understand the environmental spread of the virus and risk of indirect transmission to inform Infection Prevention and Control (IPC) measures in these settings. Methods: Upon notification of SARS-CoV-2 outbreaks, LTCF within a local authority in the South West of England were approached to take part in this pilot study. Investigators visited to swab common touch-points and elevated ‘non-touch’ surfaces and samples were analysed for presence of SARS-CoV-2 genetic material (RNA). Data were collected regarding LTCF infrastructure, staff behaviours, clinical and epidemiological risk factors for infection (staff and residents), and IPC measures. Criteria for success were: recruitment of three LTCF; detection of SARS-COV-2 RNA; variation in proportion of SARS-CoV-2 positive surfaces by sampling zone; potential to assess infection risk from SARS-CoV-2 positive surfaces. Results: Three LTCFs were recruited, ranging in size and resident demographics. Outbreaks lasted 63, 50 and 30 days with resident attack rates of 53%, 40% and 8%, respectively. The proportion of sample sites on which SARS-CoV-2 was detected was highest in rooms occupied by infected residents and varied elsewhere in the LTCF, with low levels in a facility implementing enhanced IPC measures. The heterogeneity of settings and difficulty obtaining data made it difficult to assess association between environmental contamination and infection. Elevated surfaces were more likely to test positive for SARS-CoV-2 RNA than common touch-points. Conclusions: SARS-CoV-2 RNA can be detected in a variety of LTCF outbreak settings. We identified variation in environmental spread which could be associated with implementation of IPC measures, though we were unable to assess the impact on infection risk. Sampling elevated surfaces could add to ongoing public health surveillance for SARS-CoV-2 and other airborne pathogens in LTCF.